Abstract
The paper presents the clinical experience of commissioning and the validation method of a commercial quality control system for radiation therapy plans based on transit dosimetry.
REFERENCES
D. E. Citrin, New England J. Med. 377, 1065 (2017).
H. H. W. Chen and M. T. Kuo, Oncotarget 8, 62742 (2017).
G. Delaney et al., Cancer 104, 1129 (2005).
S. Chiavassa et al., Brit. J. Radiol. 92, 20190270 (2019).
T. K. Yeung et al., Radiother. Oncol. 74, 283 (2005).
J. E. Bekelman et al., Int. J. Rad. Oncol. Biol. Phys. 83, 782 (2012).
E. E. Klein et al., Med. Phys. 36, 4197 (2009).
B. Fraass et al., Med. Phys. 25, 1773 (1998).
L. Masi et al., Med. Phys. 38, 612 (2011).
L. Delombaerde et al., Phys. Imaging Rad. Oncol. 20, 51 (2021).
I. Olaciregui-Ruiz et al., Phys. Imaging Rad. Oncol. 15, 108 (2020).
J. I. Park et al., Rad. Oncol. 11, 1 (2016).
C. Bojechko et al., Med. Phys. 42, 5363 (2015).
M. Esposito et al., Strahlenther. Onkol. 197, 633 (2021).
A. H. Zhuang and A. J. Olch, J. Appl. Clin. Med. Phys. 19, 114 (2018).
D. Thwaites, J. Phys.: Conf. Ser. 444, 012006 (2013).
H. Zhen et al., J. Appl. Clin. Med. Phys. 16, 181 (2015).
Funding
This work was supported by the Russian Science Foundation, project no. 22-25-00293, https://rscf.ru/project/22-25-00293/.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The authors of this work declare that they have no conflict of interest.
Additional information
Translated by Sh. Galyaltdinov
Publisher’s Note.
Pleiades Publishing remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ismailova, A.A., Zavestovskaya, I.N., Gromova, N.V. et al. Commissioning and Validation Method of the Quality Control System of Radiation Therapy Plans Based on Transit Dosimetry. Phys. Atom. Nuclei 86, 2531–2534 (2023). https://doi.org/10.1134/S1063778823110182
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1063778823110182